MedTrace Logo

Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening

NCT03938623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2019-05-06

No results posted yet for this study

Summary

Context : Colorectal cancer (CRC) mass screening has been implemented in France since 2008. Participation rates remain too low. The objective of this study is to test if the implementation of a training course focused on communication skills (whether in-person or e-learning) among general practitioners (GP) would increase the delivery of gFOBT and CRC screening participation among the target population of each participating GP.

Method : Pragmatic controlled cluster randomized trial with 2 parallel groups: Control versus Educational Intervention Intervention ; six hour educational training either in person or through e-learning The Main objective: is to evaluate the effectiveness of an educational intervention teaching physicians the patient-centered approach, either in-person or through e-learning, by evaluating their patients' participation in colorectal cancer (CRC) screening for all risk categories.

Conditions

Interventions

OTHER

Training

Teaching general practitioners to use the patient-centered approach when suggesting colorectal cancer screening

Sponsors & Collaborators

  • National Cancer Institute, France

    collaborator OTHER_GOV

  • Collège de la Médecine Générale, France

    lead OTHER

Principal Investigators

  • AUBIN-AUGER M ISABELLE, MD, Pr · COLLEGE DE LA MEDECINE GENERALE

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-24
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938623 on ClinicalTrials.gov